PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Nitroglycerin and Aspirin Interaction

Drug interaction information between Nitroglycerin and Aspirin.

Nitroglycerin and Aspirin have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Nitroglycerin and Aspirin. Major interactions are generally avoided, moderate ones may need monitoring or a dose adjustment, and minor ones are usually low-risk. This page shows the documented mechanism and guidance. Label-documented interactions are not a complete safety review, so always confirm your own medications with a pharmacist or doctor. Educational information, not medical advice.

Drug A

Nitroglycerin

Nitrate Vasodilator

Drug B

Aspirin

Antiplatelet / NSAID

How They Interact

Taking high doses of aspirin can increase the amount of nitroglycerin in your blood. This makes the nitroglycerin work more strongly to widen your blood vessels and lower your blood pressure.

What To Do

Your doctor may need to monitor your blood pressure more closely or adjust your medication doses if you take high-dose aspirin.

FDA Label Information

Drug interactions Aspirin: Coadministration of nitroglycerin with high dose aspirin (1000 mg) results in increased exposure to nitroglycerin. The vasodilatory and hemodynamic effects of nitroglycerin may be enhanced by concomitant administration of nitroglycerin with high dose aspirin.

Frequently Asked Questions

Can I take Nitroglycerin and Aspirin together?

This is a minor interaction. Your doctor may need to monitor your blood pressure more closely or adjust your medication doses if you take high-dose aspirin.

How serious is the interaction between Nitroglycerin and Aspirin?

This interaction is classified as "minor" severity by the FDA. Minor interactions are unlikely to cause significant problems but should still be mentioned to your healthcare provider.

Why do Nitroglycerin and Aspirin interact?

Taking high doses of aspirin can increase the amount of nitroglycerin in your blood. This makes the nitroglycerin work more strongly to widen your blood vessels and lower your blood pressure.

Understanding the Nitroglycerin and Aspirin Interaction

FDA-approved prescribing information for these two drugs flags their combination as a minor-severity interaction. Nitroglycerin belongs to the Nitrate Vasodilator class and Aspirin belongs to the Antiplatelet / NSAID class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Taking high doses of aspirin can increase the amount of nitroglycerin in your blood. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Nitroglycerin has 8 total documented interactions on file in this dataset, and Aspirin has 47. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Your doctor may need to monitor your blood pressure more closely or adjust your medication doses if you take high-dose aspirin. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Nitroglycerin or Aspirin based on a web page, speak with your prescriber or pharmacist before making any change.

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. Always consult your healthcare provider about drug interactions.